These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 22169357)

  • 21. Ex vivo proton MR spectroscopy (1H-MRS) for evaluation of human gastric carcinoma.
    Mun CW; Cho JY; Shin WJ; Choi KS; Eun CK; Cha SS; Lee J; Yang YI; Nam SH; Kim J; Lee SY
    Magn Reson Imaging; 2004 Jul; 22(6):861-70. PubMed ID: 15234456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral-maxillofacial malignant tumors: an initial study with in vivo single-voxel 1H MR spectroscopy].
    Yu Q; Wang PZ; Shi HM; Luo JC
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jan; 42(1):18-20. PubMed ID: 17331436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of quantitative proton MR spectroscopy in the differentiation of benign and malignant meningioma.
    Yue Q; Isobe T; Shibata Y; Kawamura H; Anno I; Matsumura A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1103-9. PubMed ID: 22295694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.
    Russo F; Mazzetti S; Grignani G; De Rosa G; Aglietta M; Anselmetti GC; Stasi M; Regge D
    Eur Radiol; 2012 May; 22(5):1131-9. PubMed ID: 22138734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical application of proton magnetic resonance spectroscopy for differential diagnosis of pediatric posterior fossa tumors].
    Zakrzewski K; Kreisel J; Polis L; Nowosławska E; Liberski PP; Biegański T
    Neurol Neurochir Pol; 2001; 35 Suppl 5():19-25. PubMed ID: 11935675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
    Matsumura A; Isobe T; Anno I; Takano S; Kawamura H
    J Clin Neurosci; 2005 May; 12(4):416-20. PubMed ID: 15925772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.
    Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W
    Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic changes in pelvic lesions: findings at proton MR spectroscopic imaging.
    Hascalik S; Celik O; Sarac K; Meydanli MM; Alkan A; Mizrak B
    Gynecol Obstet Invest; 2005; 60(3):121-7. PubMed ID: 15920339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative multivoxel proton chemical shift imaging of the breast.
    Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M
    Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic characterization of primary and metastatic ovarian cancer by 1H-MRS in vivo at 3T.
    McLean MA; Priest AN; Joubert I; Lomas DJ; Kataoka MY; Earl H; Crawford R; Brenton JD; Griffiths JR; Sala E
    Magn Reson Med; 2009 Oct; 62(4):855-61. PubMed ID: 19645005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
    J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
    Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
    Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of contrast material on the metabolite ratios in single-voxel MR Spectroscopy of intraaxial brain tumors.
    Alkan A; Burulday V; Oztanir N; Dogan M; Erbay MF; Kocak A; Aralasmak A
    Med Hypotheses; 2012 Aug; 79(2):129-31. PubMed ID: 22560442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of single voxel 1H MR spectroscopic imaging at 3T for the differentiation of benign and malign breast lesions.
    Ramazan A; Demircioglu O; Ugurlu U; Kaya H; Aribal E
    Clin Imaging; 2016; 40(5):831-6. PubMed ID: 27179154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of 3 Tesla proton MR spectroscopy, MR perfusion and MR diffusion for distinguishing glioma recurrence from posttreatment effects.
    Fink JR; Carr RB; Matsusue E; Iyer RS; Rockhill JK; Haynor DR; Maravilla KR
    J Magn Reson Imaging; 2012 Jan; 35(1):56-63. PubMed ID: 22002882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo 1H MRS for musculoskeletal lesion characterization: which factors affect diagnostic accuracy?
    Wang CK; Li CW; Hsieh TJ; Lin CJ; Chien SH; Tsai KB; Chang KC; Tsai HM
    NMR Biomed; 2012 Feb; 25(2):359-68. PubMed ID: 21793078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human breast lesions: characterization with proton MR spectroscopy.
    Roebuck JR; Cecil KM; Schnall MD; Lenkinski RE
    Radiology; 1998 Oct; 209(1):269-75. PubMed ID: 9769842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma.
    Yamasaki F; Takayasu T; Nosaka R; Amatya VJ; Doskaliyev A; Akiyama Y; Tominaga A; Takeshima Y; Sugiyama K; Kurisu K
    J Neurosurg; 2015 Jun; 122(6):1370-9. PubMed ID: 25748300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor.
    Oya N; Aoki J; Shinozaki T; Watanabe H; Takagishi K; Endo K
    Radiat Med; 2000; 18(3):193-8. PubMed ID: 10972550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.